KEGG   DISEASE: Amyotrophic lateral sclerosis (ALS)
H00058                      Disease                                

Amyotrophic lateral sclerosis (ALS);
Lou Gehrig disease
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by a progressive degeneration of motor neurons in the brain and spinal cord. In 90% of patients, ALS is sporadic, with no clear genetic linkage. On the other hand, the remaining 10% of cases show familial inheritance, with mutations in SOD1, TDP43(TARDBP), FUS, or C9orf72 genes being the most frequent causes. In spite of such difference, familial ALS and sporadic ALS have similarities in their pathological features. Proposed disease mechanisms contributing to motor neuron degeneration in ALS are: impaired proteostasis, aberrant RNA processing, mitochondrial disfunction and oxidative stress, microglia activation, and axonal dysfunction.
Neurodegenerative disease
Human diseases [BR:br08402]
 Nervous system diseases
  Neurodegenerative diseases
   H00058  Amyotrophic lateral sclerosis (ALS)
Human diseases in ICD-11 classification [BR:br08403]
 08 Diseases of the nervous system
  Motor neuron diseases or related disorders
   8B60  Motor neuron disease
    H00058  Amyotrophic lateral sclerosis (ALS)
hsa05014  Amyotrophic lateral sclerosis
hsa05022  Pathways of neurodegeneration - multiple diseases
nt06410  Calcium signaling
nt06412  Unfolded protein response (UPR) signaling
nt06413  Autophagy
nt06414  Apoptosis
nt06415  PI3K signaling
nt06418  Oxidative phosphorylation
nt06419  Microtubule-based transport
nt06420  Ubiquitin-proteasome system
nt06421  Mitophagy
nt06423  Cytoskeletal regulation
nt06424  RNA processing
nt06464  Amyotrophic lateral sclerosis
N01135  Mutation-caused aberrant SOD1 to intrinsic apoptotic pathway
N01136  Mutation-caused aberrant TDP43 to electron transfer in Complex I
N01138  Mutation-inactivated OPTN to PINK-Parkin-mediated autophagosome formation
N01139  Mutation-inactivated p62 to PINK-Parkin-mediated autophagosome formation
N01141  Mutation-inactivated TBK1 to TBK1-mediated autophagosome formation
N01143  Mutation-inactivated C9orf72 to C9orf72-mediated autophagy initiation
N01144  Mutation-caused aberrant SOD1 to 26S proteasome-mediated protein degradation
N01145  Mutation-inactivated VCP to 26S proteasome-mediated protein degradation
N01146  Mutation-inactivated UBQLN2 to 26S proteasome-mediated protein degradation
N01147  Mutation-caused aberrant SOD1 to ATF6-mediated transcription
N01148  Mutation-caused aberrant SOD1 to IRE1a-XBP1 signaling pathway
N01149  Mutation-caused aberrant SOD1 to PERK-ATF4 signaling pathway
N01150  Mutation-inactivated VAPB to ATF6-mediated transcription
N01151  Mutation-inactivated SIGMAR1 to Ca2+ -apoptotic pathway
N01153  Mutation-caused aberrant GLE1 to nuclear export of mRNA
N01155  Mutation-caused aberrant TDP43 to TDP-43-regulated splicing
N01157  Mutation-caused aberrant FUS to FUS-regulated splicing
N01158  Mutation-caused aberrant DCTN1 to retrograde axonal transport
N01159  Mutation-caused aberrant TUBA4A to retrograde axonal transport
N01160  Mutation-caused aberrant SOD1 to retrograde axonal transport
N01162  Mutation-caused aberrant PFN1 to actin polymerization
N01164  Mutation-inactivated ERBB4 to NRG-ERBB4-PI3K signaling pathway
(ALS1) SOD1; superoxide dismutase (mutation) [HSA:6647] [KO:K04565]
(ALS1) NEFH; neurofilament (deletion/insertion) [HSA:4744] [KO:K04574]
(ALS1) PRPH; peripherin (deletion) [HSA:5630] [KO:K07607]
(ALS1) DCTN1; dynactin 1 (mutation) [HSA:1639] [KO:K04648]
(ALS2) ALS2; alsin (mutation) [HSA:57679] [KO:K04575]
(ALS4) SETX; senataxin (mutation) [HSA:23064] [KO:K10706]
(ALS5) SPG11 [HSA:80208] [KO:K19026]
(ALS6) FUS; fusion (mutation) [HSA:2521] [KO:K13098]
(ALS8) VAPB; VAMP-associated protein (mutation) [HSA:9217] [KO:K10707]
(ALS9) ANG; angiogenin (mutation) [HSA:283] [KO:K16631]
(ALS10) TARDBP; TAR DNA binding protein (mutation) [HSA:23435] [KO:K23600]
(ALS11) FIG4; FIG4 homolog (mutation) [HSA:9896] [KO:K22913]
(ALS12) OPTN; optineurin (mutation) [HSA:10133] [KO:K19946]
(ALS14) VCP [HSA:7415] [KO:K13525]
(ALS15) UBQLN2 [HSA:29978] [KO:K04523]
(ALS16) SIGMAR1 [HSA:10280] [KO:K20719]
(ALS17) CHMP2B [HSA:25978] [KO:K12192]
(ALS18) PFN1 [HSA:5216] [KO:K05759]
(ALS19) ERBB4 [HSA:2066] [KO:K05085]
(ALS20) HNRNPA1 [HSA:3178] [KO:K12741]
(ALS21) MATR3 [HSA:9782] [KO:K13213]
(ALS22) TUBA4A [HSA:7277] [KO:K07374]
(ALS23) ANXA11 [HSA:311] [KO:K17095]
(FTD-ALS1) C9ORF72 [HSA:203228] [KO:K23609]
(FTD-ALS2) CHCHD10 [HSA:400916] [KO:K22759]
(FTD-ALS3) SQSTM1 [HSA:8878] [KO:K14381]
(FTD-ALS4) TBK1 [HSA:29110] [KO:K05410]
MAPT; microtubule-associated protein tau [HSA:4137] [KO:K04380]
GLE1 [HSA:2733] [KO:K18723]
(ALS/PDC) TRPM7 [HSA:54822] [KO:K04982]
Riluzole [DR:D00775]
Edaravone [DR:D01552]
Affected region: motor cortex, brain stem, spinal cord
Microscopic lesion: hyaline inclusions
Other DBs
ICD-11: 8B60.0
ICD-10: G12.2
MeSH: D000690
OMIM: 105400 205100 602433 602099 608030 608627 611895 612069 612577 613435 613954 300857 614373 614696 614808 615515 615426 606070 617839 616208 617839 105550 615911 616437 616439
PMID:30870681 (gene)
Mathis S, Goizet C, Soulages A, Vallat JM, Masson GL
Genetics of amyotrophic lateral sclerosis: A review.
J Neurol Sci 399:217-226 (2019)
PMID:28980624 (gene)
Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH
Amyotrophic lateral sclerosis.
Nat Rev Dis Primers 3:17071 (2017)
PMID:19251628 (ALS6)
Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P, Ganesalingam J, Williams KL, Tripathi V, Al-Saraj S, Al-Chalabi A, Leigh PN, Blair IP, Nicholson G, de Belleroche J, Gallo JM, Miller CC, Shaw CE
Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6.
Science 323:1208-11 (2009)
PMID:19251627 (ALS6)
Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, Valdmanis P, Rouleau GA, Hosler BA, Cortelli P, de Jong PJ, Yoshinaga Y, Haines JL, Pericak-Vance MA, Yan J, Ticozzi N, Siddique T, McKenna-Yasek D, Sapp PC, Horvitz HR, Landers JE, Brown RH Jr
Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis.
Science 323:1205-8 (2009)
PMID:19118816 (ALS11)
Chow CY, Landers JE, Bergren SK, Sapp PC, Grant AE, Jones JM, Everett L, Lenk GM, McKenna-Yasek DM, Weisman LS, Figlewicz D, Brown RH, Meisler MH
Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS.
Am J Hum Genet 84:85-8 (2009)
PMID:19081518 (drug)
Turner MR, Kiernan MC, Leigh PN, Talbot K
Biomarkers in amyotrophic lateral sclerosis.
Lancet Neurol 8:94-109 (2009)
PMID:18802454 (ALS10)
Rutherford NJ, Zhang YJ, Baker M, Gass JM, Finch NA, Xu YF, Stewart H, Kelley BJ, Kuntz K, Crook RJ, Sreedharan J, Vance C, Sorenson E, Lippa C, Bigio EH, Geschwind DH, Knopman DS, Mitsumoto H, Petersen RC, Cashman NR, Hutton M, Shaw CE, Boylan KB, Boeve B, Graff-Radford NR, Wszolek ZK, Caselli RJ, Dickson DW, Mackenzie IR, Petrucelli L, Rademakers R
Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis.
PLoS Genet 4:e1000193 (2008)
Pasinelli P, Brown RH
Molecular biology of amyotrophic lateral sclerosis: insights from genetics.
Nat Rev Neurosci 7:710-23 (2006)
Gros-Louis F, Gaspar C, Rouleau GA
Genetics of familial and sporadic amyotrophic lateral sclerosis.
Biochim Biophys Acta 1762:956-72 (2006)
PMID:16501576 (ALS9)
Greenway MJ, Andersen PM, Russ C, Ennis S, Cashman S, Donaghy C, Patterson V, Swingler R, Kieran D, Prehn J, Morrison KE, Green A, Acharya KR, Brown RH Jr, Hardiman O
ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis.
Nat Genet 38:411-3 (2006)
PMID:15952898 (ALS1)
Valentine JS, Doucette PA, Zittin Potter S
Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis.
Annu Rev Biochem 74:563-93 (2005)
PMID:15478096 (ALS4)
Kunst CB
Complex genetics of amyotrophic lateral sclerosis.
Am J Hum Genet 75:933-47 (2004)
Chen YZ, Bennett CL, Huynh HM, Blair IP, Puls I, Irobi J, Dierick I, Abel A, Kennerson ML, Rabin BA, Nicholson GA, Auer-Grumbach M, Wagner K, De Jonghe P, Griffin JW, Fischbeck KH, Timmerman V, Cornblath DR, Chance PF
DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4).
Am J Hum Genet 74:1128-35 (2004)
Julien JP.
Amyotrophic lateral sclerosis. unfolding the toxicity of the misfolded.
Cell 104:581-91 (2001)
PMID:20428114 (ALS12)
Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, Kinoshita Y, Kamada M, Nodera H, Suzuki H, Komure O, Matsuura S, Kobatake K, Morimoto N, Abe K, Suzuki N, Aoki M, Kawata A, Hirai T, Kato T, Ogasawara K, Hirano A, Takumi T, Kusaka H, Hagiwara K, Kaji R, Kawakami H
Mutations of optineurin in amyotrophic lateral sclerosis.
Nature 465:223-6 (2010)
Yamashita S, Ando Y
Genotype-phenotype relationship in hereditary amyotrophic lateral sclerosis.
Transl Neurodegener 4:13 (2015)
Sieh W, Choi Y, Chapman NH, Craig UK, Steinbart EJ, Rothstein JH, Oyanagi K, Garruto RM, Bird TD, Galasko DR, Schellenberg GD, Wijsman EM
Identification of novel susceptibility loci for Guam neurodegenerative disease: challenges of genome scans in genetic isolates.
Hum Mol Genet 18:3725-38 (2009)

» Japanese version

DBGET integrated database retrieval system